Skip to main content

Advertisement

Log in

Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Aim

To evaluate whether the presence of specific polymorphism in the gene promoter of collagen and some matrix metalloproteinases was associated with the risk of developing pelvic organ prolapse.

Methods

A case–control study was carried on 233 women: 137 were cases with ≥stage II pelvic organ prolapse and 96 were matched controls without pelvic pathologies. Allele and genotype frequencies related to polymorphisms at the Sp1 site of type I collagen and some functional polymorphisms in the promoters of metalloproteinases-1, -3 and -9 have been compared between groups. It has been shown that these single-insertions/deletions polymorphisms located in the promoter region of the genes have a functional significance in the regulation of their transcriptional level and local expression. Genotypes were determined by polymerase chain reaction (PCR) amplification and sequence analysis. SPSS 14.0 software was used for data analysis. Probability values of <0.05 were considered statistically significant.

Results

No difference between groups was found in the genotype distribution polymorphisms for COL1A1, metalloproteinases-9 and -3, while the distribution of the polymorphism of metalloproteinases-1 was significantly increased in the cases when compared with controls (p = 0.04).

Conclusions

Our findings suggest that the polymorphism of metalloproteinases-1 might have a role in mediating susceptibility to pelvic organ prolapse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506

    Article  PubMed  CAS  Google Scholar 

  2. Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E (2002) Pelvic organ prolapse surgery in the United States. Am J Obstet Gynecol 186:712–716

    Article  PubMed  Google Scholar 

  3. Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Ba SW (2007) Risk factors for pelvic organ prolapse. Int J Gynecol Obstet 98:248–251

    Article  CAS  Google Scholar 

  4. Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 104:489–497

    Article  PubMed  Google Scholar 

  5. Chiaffarino F, Chatenoud L, Dindelli M, Meschia M, Buonaguidi A, Amicarelli F et al (1999) Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol and Reprod Biol 82:63–67

    Article  CAS  Google Scholar 

  6. Carley ME, Schaffer J (2000) Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers–Danlos syndrome. Am J Obstet Gynecol 182:1021–1023

    Article  PubMed  CAS  Google Scholar 

  7. Gabriel B, Watermann D, Hancke K, Gitsch G, Werner M, Tempfer C et al (2006) Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse. Int Urogynecol 17:478–482

    Article  Google Scholar 

  8. Vulic M, Strinic T, Bukovic D, Tomic S, Zupic T, Pavic M et al (2010) Expression of matrix metalloproiteinase-1 in uterosacral ligaments tissue of women with genital prolapse. Coll Antropol 34:1411–1414

    PubMed  CAS  Google Scholar 

  9. Dviri M, Leron E, Dreiher J, Mazor M, Shaco-Levy R (2011) Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 156:113–117

    Article  PubMed  CAS  Google Scholar 

  10. Strittmatter WJ, Roses AD (1995) Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci 92:4725–4727

    Article  PubMed  CAS  Google Scholar 

  11. Dunleavey L, Beyzade S, Ye S (2000) Rapid genetype analysis of the matrix metalloproteinases 1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 19:175–177

    Article  PubMed  CAS  Google Scholar 

  12. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary aterosclerosis. Br Heart J 73:209–215

    Article  PubMed  CAS  Google Scholar 

  13. Yamada Y, Ando F, Niino N, Shimokata H (2004) Association af a polymorphism of the matrix-metaloproteinase-9 gene with bone mineral density in Japanese women. Metab Clin Ex 53:135–137

    Article  CAS  Google Scholar 

  14. Bump RC, Mattiasson A, Bo K, Brubaker L, DeLancey JOL, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17

    Article  PubMed  CAS  Google Scholar 

  15. Vinkanharju A, Melkko T, Risteli J, Risteli L (2001) New PCR-based method for the Sp1 site polymorphism in the COL1A1 gene. Clin Chem Lab Med 39:624–636

    Article  PubMed  CAS  Google Scholar 

  16. Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K (2001) Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 289:116–119

    Article  PubMed  CAS  Google Scholar 

  17. Biondi ML, Ghilardi G, Mangoni J, Scorza R, Leviti S, Guagnellini E (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Canc Res 7:2344–2346

    Google Scholar 

  18. Szyllo K, Smolarz H, Makowska H, Niewiadornski M, Kozlowska E, Kulig A (2002) The promoter polymorphism of the matrix metalloproteinase 3 [MMP-3] gene in women with ovarian cancer. Exp Clin Cancer Res 21:357–362

    CAS  Google Scholar 

  19. Luber KM, Boero S, Choe JY (2001) The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol 184:1496–1503

    Article  PubMed  CAS  Google Scholar 

  20. Tegerstedt G, Miedel A, Maehle-Schmidt M, Nyrén O, Hammarström M (2006) Obstetric risk factors for symptomatic prolapse: a population-based approach. Am J Obstet Gynecol 194:75–81

    Article  PubMed  Google Scholar 

  21. Jack GS, Nikolova G, Vilain E, Raz S, Rodríguez LV (2006) Familiar transmission of genitovaginal prolapses. Int Urogynecol J 17:498–501

    Article  Google Scholar 

  22. Campeau L, Gorbachinsky I, Badlani GH, Andersson KE (2011) Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int 108:1240–1247

    Article  PubMed  CAS  Google Scholar 

  23. Gabriel B, Denschlag D, Göbel H, Fittkow C, Werner M, Gitsch G et al (2005) Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse. Int Urogynecol J 16:475–479

    Article  Google Scholar 

  24. Ewies AA, Al-Azzawi F, Thompson J (2003) Changes in extracellular matrix proteins in the cardinal ligaments of postmenopausal women with or without prolapse: a computerized immunohistomorphometric analysis. Hum Reprod 18:2189–2195

    Article  PubMed  CAS  Google Scholar 

  25. Barbiero EC, Sartori MG, Girão MJ, Baracat EC, de Lima GR (2003) Analysis of type I collagen in the parametrium of women with and without uterine prolapse, according to hormonal status. Int Urogynecol J 14:331–334

    Article  Google Scholar 

  26. Cho H, Jung H, Kim S, Choi J, Cho N, Bai S (2009) Polymorphism of COLIA1 gene Sp1 binding site in Korean women with pelvic organ prolapse. Yonsei Med J 50:564–568

    Article  PubMed  CAS  Google Scholar 

  27. Woessner JF Jr (1994) The family of matrix metalloproteinases. Ann N Y Acad Sci 732:11–21

    Article  PubMed  CAS  Google Scholar 

  28. Hojilla CV, Mohammed FF, Khokha R (2003) Matrix metallproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89:1817–1821

    Article  PubMed  CAS  Google Scholar 

  29. Chen BH, Wen Y, Li H, Polan ML (2002) Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J 13:80–88

    Article  CAS  Google Scholar 

  30. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996) Changes in the metabolism of collagen in genitourinary prolapse. Lancet 347:1658–1661

    Article  PubMed  CAS  Google Scholar 

  31. Chen HY, Lin WY, Chen YH, Chen WC, Tsai FJ, Tsai CH (2010) Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women. Eur J Obstet Gynecol Reprod Biol 149:222–224

    Article  PubMed  CAS  Google Scholar 

  32. Skorupski P, Miotła P, Jankiewicz K, Rechberger T (2010) MMP-1 and MMP-3 gene encoding polymorphism and the risk of the development of pelvic organ prolapse and stress urinary incontinence. Ginekol Pol 81:594–599

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no financial, personal, political, intellectual or religious interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Meschia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrari, M.M., Rossi, G., Biondi, M.L. et al. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet 285, 1581–1586 (2012). https://doi.org/10.1007/s00404-011-2199-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-2199-9

Keywords

Navigation